(Neuro Kinetics, Inc.) A new paper describes the objective and effective use of I-Portal® technology to test and monitor mTBI patients over time. The authors conclude the testing paradigm will allow investigators to institute better treatments and provide more accurate return to activity advice. Six measures from five tests were found to classify the control and mTBI patients with extremely high sensitivity and specificity.
############
Story Source: Materials provided by Scienmag
